IGF-1 raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-07-09 and is reviewed periodically as new material appears.
Interest in AOD-9604 arose from attempts to separate metabolic effects from growth effects attributed to hGH. Early work explored whether the fragment could influence lipolysis or fat oxidation without promoting growth. Those questions remain partly unresolved because human data are limited and results have varied across studies. The peptide is not a hormone replacement for hGH and is not equivalent to hGH in clinical use. Its research history includes both laboratory studies and commercial marketing claims that are not the same as regulatory approval.
AOD-9604 is a synthetic peptide whose structure corresponds to a C-terminal segment of human growth hormone. It is often described as hGH fragment 176-191, a 16-amino-acid sequence. The peptide was designed to isolate a region of hGH associated with fat metabolism while avoiding the full hormone's growth-promoting actions. Laboratory and commercial materials typically present it as a lyophilized powder for research use. Its identity is defined by amino acid sequence, not by a single brand.
The fragment includes residues that can form an internal disulfide bond between two cysteine positions. This structural feature can influence how the peptide folds and how stable it is in solution. AOD-9604 differs from full-length hGH in size and receptor interactions; it does not contain the entire growth hormone sequence. Published descriptions sometimes use slightly different residue numbering, so sequence information should be checked against primary sources. The molecule is small compared with intact hGH, which affects analytical detection and purification approaches.
Quality varies among research-grade suppliers, so certificates of analysis and independent testing are important for verification. A typical certificate reports purity by HPLC, identity by mass spectrometry, appearance, and sometimes residual solvents or water content. AOD9604 is often sold as a research chemical not intended for human consumption, and labels can be inaccurate. Common misconceptions include treating the peptide as a form of growth hormone, assuming supplement status, or expecting approved-drug quality from unregulated products.
AOD9604 is commonly supplied as a white to off-white lyophilized powder. The powder is typically stored at -20 °C or below, protected from light and moisture, because peptides can degrade through oxidation, hydrolysis, or aggregation. If it is reconstituted for laboratory use, an appropriate aqueous buffer or solvent is chosen, and the solution is kept cold and handled to avoid repeated freeze-thaw cycles. These practices support stability but do not imply suitability for human use.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Based on the C-terminal region of human growth hormone. |
| Amino acid length | 16 residues | Often described as hGH fragment 176-191. |
| Appearance | Lyophilized powder | Typically white to off-white; exact appearance depends on grade. |
| Solubility | Soluble in water | Aqueous solubility depends on pH, ionic strength, and preparation. |
| Typical storage | -20 °C or lower | Lyophilized peptide is usually kept cold and dry; solutions may require freezing. |
Regulatory treatment of AOD-9604 has varied. In sports anti-doping, the peptide became widely discussed during a 2013 investigation into an Australian professional sports club. Authorities at the time debated whether it fell under prohibitions on growth hormone and related substances. Later clarifications and updated lists have addressed the compound in different ways. Anyone seeking current status should consult the latest applicable rules, and commercial supply for human use is not authorized in major markets.
Research interest in AOD-9604 often focuses on whether it can influence lipid metabolism without the growth-promoting or glucose-related effects of full-length hGH. This question remains unresolved, and findings depend on model, dose, and measurement method. Some reviews treat the peptide as a historical obesity candidate rather than an active therapeutic. Others cite it in discussions of peptide fragments, metabolic signaling, and performance-enhancing substances. Clear conclusions are limited by the small number of rigorous, independent human studies.
AOD-9604 has been investigated primarily as a potential treatment for obesity and related metabolic conditions. Early laboratory work examined its effects on fat cells, and later studies moved into animal models and human clinical trials. Some trials reportedly reached Phase II, but the program did not lead to an approved medicine. Published summaries often note that weight-loss results were modest or inconsistent. The full trial data are not all publicly available in detail.
Regulatory treatment of AOD-9604 is shaped by its classification as a peptide hormone. The World Anti-Doping Agency lists it as a prohibited substance, and many national anti-doping organizations adopt that list. It does not hold approval as a prescription medicine in the United States, the European Union, or other major markets. Products sold online are frequently labeled for research use only and may not undergo independent quality testing. Import and possession rules differ by country, so legal status depends on local law.
Proposed mechanisms for AOD-9604 focus on fat cells. Laboratory studies suggest the peptide can increase lipolysis, the breakdown of stored fat, and reduce lipogenesis, the formation of new fat. Unlike full human growth hormone, it does not appear to stimulate substantial IGF-1 production in the studies reported so far. Some evidence points to beta-adrenergic signaling, but the precise receptor targets and downstream pathways remain unresolved. The fragment is not thought to act through the classical growth hormone receptor.
=== Biomonitoring === Xanthoria parietina is an effective biomonitor for tracking air pollution trends and heavy metal accumulation over time. A seven-year study in Adriatic Italy measured nine heavy metals (Cd, Cr, Ni, Pb, V, Cu, Zn, Fe, Al) in 51 locations, revealing spatial and temporal pollution patterns. During the study, Cr, Ni, Zn, Fe, and Al levels increased, likely due to industrial and vehicular emissions, while Pb levels declined, reflecting the phase-out of leaded gasoline. The study also identified pollution hotspots, with elevated vanadium levels near oil refineries (a marker of fossil fuel combustion) and higher copper and zinc concentrations in urban areas, likely from traffic and industry. Statistical analyses showed that Al, Fe, Cr, and Ni were linked to industrial emissions and resuspended soil dust, while Cd, Zn, Cu, and V were associated with oil refinery activities and long-range pollutant transport. This ability to differentiate pollution sources makes X. parietina a valuable tool for environmental forensics and pollution source attribution. In addition to pollution mapping, X. parietina is used in environmental health risk assessments, identifying areas with persistent heavy metal accumulation that may indicate higher human exposure to airborne contaminants. One advantage of lichen biomonitoring is that it provides a cost-effective alternative to air-quality networks, which require specialized equipment and infrastructure.
Tissue engineering aims to replace lost or damaged tissues within the body. The success of such efforts has depended greatly upon the ability to direct cell behavior and encourage regeneration of tissues. A key method of doing so utilizes ECM-derived ligands such as RGD to control cellular responses to a biomaterial, such as attachment, proliferation, and differentiation.
== The "Discipline" == In the novel, avout follow a life path called the Discipline, sometimes referred to as Cartasian Discipline, after Saunt Cartas, the founder of the mathic world. It is a set of rules governing what is (and is not) allowed for avout to know and/or do, and was codified centuries before the time of the story in the Second New Revised Book of Discipline. Chief among these is that the avout are separated from the Sæculum, or outside world. There are different levels of separation. For example, within a concent, there are different terms of residency. There are 1-, 10-, 100-, and 1,000-year orders. Each of these celebrates "Apert", a festival opening the concent to the outside world and allowing the flow of information between them, on an interval determined by that number. For example, a 10-year order would celebrate Apert once every ten years, remaining isolated otherwise. Likewise, a 100-year order would only celebrate Apert every hundred years, and a 1,000-year order once every 1,000 years. It is an essential part of this that at any time an order celebrates Apert, all orders below it also celebrate Apert. For example, a Millenarian (1,000-year) order would celebrate in the year 3000. Because 3000 is also a multiple of 100, 10, and 1, Centenarian, Decenarian, and Unarian orders would also celebrate. Exceptions to this rule include "hierarchs" (those who administer the concent) who are required to confer with the Sæcular Power on decisions of weight.
== Toponymy == The origin of the name Billericay is unclear. It was first recorded as Byllyrica in 1291. The urban settlement, which was within the manor and parish of Great Burstead, was one of many founded in the late 13th century in an already densely populated rural landscape. Several suggestions for the origin of the place name include:
== Definition == Reactive oxygen species (ROS) are not uniformly defined, but generally include superoxide, singlet oxygen, and hydroxyl radical. Hydrogen peroxide is not nearly as reactive as these species, but is readily activated and is thus included. Peroxynitrite and nitric oxide are also reactive oxygen-containing species.
Sources: en.wikipedia.org
These included French pharmacist Alexandre Rouhier's Le Peyotl: La Plante Qui Fait les Yeux Émerveillés (Peyote: The Plant That Fills the Eyes with Marvels) in 1927, the German psychiatrist Kurt Beringer's Der Meskalinrausch, seine Geschichte und Erscheinungsweise (Mescaline Intoxication, its History and Manifestation) in 1927, and German–American psychologist Heinrich Klüver's Mescal: The Divine Plant and Its Psychological Effects in 1928. Studies of the potential therapeutic effects of mescaline started in the 1950s. It was studied as part of psychedelic-assisted psychotherapy by Walter Frederking by 1953. Aldous Huxley's book The Doors of Perception, about his experience with mescaline, was published in 1954. In 1955, English politician Christopher Mayhew took part in an experiment for BBC's Panorama, in which he ingested 400 mg of mescaline under the supervision of psychiatrist Humphry Osmond. Though the recording was deemed too controversial and ultimately omitted from the show, Mayhew praised the experience, calling it "the most interesting thing I ever did" and saying that it was "profoundly thought-provoking". The mechanism of action of mescaline, activation of the serotonin 5-HT2A receptors, became fully known in the 1990s. A serotonin 5-HT2A receptor antagonist, specifically ketanserin, was first clearly shown to block the psychedelic effects of mescaline in humans by Matthias Liechti and colleagues in 2024. The history of mescaline was reviewed in the 2019 book Mescaline: A Global History of the First Psychedelic by cultural historian Mike Jay.
The ability of interferon to induce protein production from interferon stimulated genes (ISGs) can also be affected. Production of protein kinase R, for example, can be disrupted in cells infected with JEV. Some viruses escape the anti-viral activities of interferons by gene (and thus protein) mutation. The H5N1 influenza virus, also known as bird flu, has resistance to interferon and other anti-viral cytokines that is attributed to a single amino acid change in its Non-Structural Protein 1 (NS1), although the precise mechanism of how this confers immunity is unclear. The relative resistance of hepatitis C virus genotype I to interferon-based therapy has been attributed in part to homology between viral envelope protein E2 and host protein kinase R, a mediator of interferon-induced suppression of viral protein translation, although mechanisms of acquired and intrinsic resistance to interferon therapy in HCV are polyfactorial.
Tegileridine, sold under the brand name Aisute, is a drug which acts as a μ-opioid receptor agonist. It is closely related to compounds such as oliceridine, TRV734, and SHR9352, and shares a similar profile as a biased agonist selective for activation of the G protein signalling pathway over β-arrestin2 recruitment. In January 2024, tegileridine was approved in China under the brand name Aisute for the treatment of moderate to severe pain after abdominal surgery.
=== Human β-casomorphin 7 === Structure: YPFVQPI Despite human beta-casein having a A2-like "P" after "I", human colostrum and early lactation-stage milk contains significant amounts of hBCM7. It is a much weaker opioid and the FVQ sequence renders it susceptible to further degradation.
Sources: en.wikipedia.org
=== Organophosphates === Organophosphates are another large class of contact insecticides. These also target the insect's nervous system. Organophosphates interfere with the enzymes acetylcholinesterase and other cholinesterases, causing an increase in synaptic acetylcholine and overstimulation of the parasympathetic nervous system, killing or disabling the insect. Organophosphate insecticides and chemical warfare nerve agents (such as sarin, tabun, soman, and VX) have the same mechanism of action. Organophosphates have a cumulative toxic effect to wildlife, so multiple exposures to the chemicals amplifies the toxicity. In the US, organophosphate use declined with the rise of substitutes. Many of these insecticides, first developed in the mid 20th century, are very poisonous. Many organophosphates do not persist in the environment.
Rémi Goulet (born 1997) is a Canadian film and television actor from Lavaltrie, Quebec, best known for his regular supporting role as Benji, the younger brother of protagonist Chuck, in the television series Pour toujours, plus un jour. He began his career as a child actor, with roles in the television series 30 vies and Tactik, and the film The Pee-Wee 3D: The Winter That Changed My Life (Les Pee-Wee 3d: L'hiver qui a changé ma vie). He had his first leading role in the 2019 film Living 100 MPH (Vivre à 100 milles à l'heure), playing a semi-fictionalized version of filmmaker Louis Bélanger. In 2020, he starred in the film The Marina (La Marina). In 2023, he was announced as playing Gilles Villeneuve in Villeneuve: The Rise of a Legend (Villeneuve : l'ascension d'une légende), which premiered as the closing film of the 2026 Toronto International Film Festival.
== Etymology == The name Pakistan was coined by Choudhry Rahmat Ali, a Pakistan Movement activist, who in January 1933 first published it (originally as "Pakstan") in a pamphlet Now or Never, using it as an acronym. Rahmat Ali explained: "It is composed of letters taken from the names of all our homelands, Indian and Asian, Panjab, Afghania, Kashmir, Sindh, and Baluchistan." He added, "Pakistan is both a Persian and Urdu word... It means the land of the Paks, the spiritually pure and clean." Etymologists note that پاک pāk, is 'pure' in Persian and Pashto and the Persian suffix ـستان -stan means 'land' or 'place of'. Rahmat Ali's concept of Pakistan only related to the northwestern area of the Indian subcontinent. He also proposed the name "Banglastan" for the Muslim areas of Bengal and "Osmanistan" for Hyderabad State, as well as a political federation between the three.
In Australia, as of 2013 the drug was authorized for prescribing for severe cases of insomnia but was restricted as a Schedule 8 medicine. In France, as of 2016 flunitrazepam was not marketed. In Germany, as of 2016 flunitrazepam is an Anlage III Betäubungsmittel (controlled substance which is allowed to be marketed and prescribed by physicians under specific provisions) and is available on a special narcotic drug prescription as the Rohypnol 1 mg film-coated tablets and several generic preparations (November 2016). In Ireland, flunitrazepam is a Schedule 3 controlled substance with strict restrictions. In Japan, flunitrazepam is marketed by Japanese pharmaceutical company Chugai under the trade name Rohypnol and is indicated for the treatment of insomnia as well as used for preanesthetic medication. In Mexico, Rohypnol is legally available. In Norway, on January 1, 2003, flunitrazepam was moved up one level in the schedule of controlled drugs and, on August 1, 2004, the manufacturer Roche removed Rohypnol from the market there altogether. In South Africa, Rohypnol is classified as a Schedule 6 drug. It is available by prescription only, and restricted to 1 mg doses.
== Theory == The behavior of ions in a homogeneous, linear, static electric or magnetic field (separately) as is found in a sector instrument is simple. The physics are described by a single equation called the Lorentz force law. This equation is the fundamental equation of all mass spectrometric techniques and applies in non-linear, non-homogeneous cases too and is an important equation in the field of electrodynamics in general.
Sources: en.wikipedia.org
It is a synthetic peptide based on a C-terminal fragment of human growth hormone. It is commonly referred to as hGH fragment 176-191 and is studied for metabolic effects rather than growth effects.
No. It represents only a short portion of the hGH sequence and lacks the full hormone's structure. As a result, its biological activity and regulatory status differ from those of prescription hGH.
The exact peptide is not typically described as a circulating hormone; it is a synthetic construct based on a natural sequence. Fragments of hGH can exist in laboratory or metabolic contexts, but AOD-9604 itself is manufactured for research.
Lyophilized AOD9604 is generally kept at -20 °C or colder, desiccated, and protected from light. Reconstituted solutions are usually refrigerated and handled to minimize repeated freeze-thaw cycles. These are general laboratory handling practices, not instructions for human use.